JP2002542820A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542820A5
JP2002542820A5 JP2000615743A JP2000615743A JP2002542820A5 JP 2002542820 A5 JP2002542820 A5 JP 2002542820A5 JP 2000615743 A JP2000615743 A JP 2000615743A JP 2000615743 A JP2000615743 A JP 2000615743A JP 2002542820 A5 JP2002542820 A5 JP 2002542820A5
Authority
JP
Japan
Prior art keywords
psa
antibody
sample
lys145
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000615743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542820A (ja
Filing date
Publication date
Priority claimed from US09/303,208 external-priority patent/US6482599B1/en
Application filed filed Critical
Publication of JP2002542820A publication Critical patent/JP2002542820A/ja
Publication of JP2002542820A5 publication Critical patent/JP2002542820A5/ja
Pending legal-status Critical Current

Links

JP2000615743A 1999-04-30 2000-04-07 良性前立腺過形成に特異的な型の前立腺特異抗原(psa)とその利用法 Pending JP2002542820A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/303,208 US6482599B1 (en) 1999-04-30 1999-04-30 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
US09/303,208 1999-04-30
PCT/US2000/009415 WO2000066718A1 (en) 1999-04-30 2000-04-07 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such

Publications (2)

Publication Number Publication Date
JP2002542820A JP2002542820A (ja) 2002-12-17
JP2002542820A5 true JP2002542820A5 (enExample) 2007-06-14

Family

ID=23171019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000615743A Pending JP2002542820A (ja) 1999-04-30 2000-04-07 良性前立腺過形成に特異的な型の前立腺特異抗原(psa)とその利用法

Country Status (6)

Country Link
US (2) US6482599B1 (enExample)
EP (1) EP1173556A1 (enExample)
JP (1) JP2002542820A (enExample)
AU (1) AU780458B2 (enExample)
CA (1) CA2371577A1 (enExample)
WO (1) WO2000066718A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807438B1 (fr) * 2000-04-10 2004-09-17 Bio Merieux Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
FI20002127A0 (fi) * 2000-09-27 2000-09-27 Artic Partners Oy Ab Uusi vasta-aine, immunomääritys ja menetelmä eturauhassyövän havaitsemiseksi
US20050037447A1 (en) * 2003-07-08 2005-02-17 Yong-Chuan Wong Protein markers for human benign prostatic hyperplasia (BPH)
CA2593184A1 (en) * 2005-01-06 2006-07-13 Eastern Virginia Medical School Apolipoprotein a-ii isoform as a biomarker for prostate cancer
EP1864134A4 (en) * 2005-02-07 2010-10-20 Univ Columbia METHOD FOR TREATING OR PREVENTING HORMONRESISTENT PROSTATE CANCER USING PROTOCADHERINE PC SPECIFIC SIRNA OR OTHER INHIBITORS OF PROTOCADHERINE PC EXPRESSION OR ACTIVITY
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
CA2853705C (en) * 2011-10-25 2021-10-12 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
US11433260B2 (en) 2015-12-21 2022-09-06 Gholam A. Peyman Cancer treatment methods using thermotherapy and/or enhanced immunotherapy
US10136820B2 (en) * 2015-12-21 2018-11-27 Gholam A. Peyman Method to visualize very early stage neoplasm or other lesions
AU2019301756A1 (en) * 2018-07-12 2021-01-28 Berg Llc Methods for differentiating benign prostatic hyperplasia from prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010292A1 (en) * 1996-09-06 1998-03-12 Centocor, Inc. Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
US5858685A (en) 1997-03-21 1999-01-12 The Board Of Trustees Of The Leland Stanford Junior University Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis

Similar Documents

Publication Publication Date Title
EP0540573B1 (en) Assay of free and complexed prostate-specific antigen (psa)
JP4274330B2 (ja) cPSAの測定方法
ES2238678T3 (es) Inmunodosificados relativos al antigeno especifico de la prostata.
Liu et al. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
JP2002542820A5 (enExample)
US5840501A (en) Determination of cPSA
EP0104527A1 (en) Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives
CA2193323C (en) Process for preparing a synthetic calibrator for use in sandwich immunoassays, which calibrator consists of an antibody against one of the antibodies used in the assay and of a sequence of the analyte
JPH05504481A (ja) 改良された抗体―酵素直接接合体及びその製造方法
US20070254317A1 (en) Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate
US6379550B1 (en) Method for detecting PSA and its molecular forms using thiophilic gel
JP4447796B2 (ja) 前立腺癌と良性前立腺肥大とを識別する方法
JP2000095799A (ja) 抗体のフレ―ムワ―ク領域から誘導される物質によるイムノアッセイの干渉の減少
Jung et al. Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions
US6686167B2 (en) Test device for detecting semen and method of use
KR910700463A (ko) 암과 관련된 헵토글로빈
Torrente-Rodríguez et al. Rapid endoglin determination in serum samples using an amperometric magneto-actuated disposable immunosensing platform
EP1007570A4 (en) Monospecific antibody reactive with fibrinogen and fibrinopeptide b
JPH05295000A (ja) 共有結合的交雑種抗体、その調製法およびこれを使用する均質的免疫検定法
EP0095089A1 (en) Improved homogeneous binding assay method and reagent system, test kit and test device therefor
JPH07191027A (ja) 糖蛋白質の分別測定法
JP2002538818A5 (enExample)
JPH0566223A (ja) 高分量分析物の測定法
JP2702616B2 (ja) Pivka−iiの測定試薬
JPS583671B2 (ja) アポグルコ−スオキシダ−ゼの、フラビンアデニンジヌクレオチド及びその誘導体と結合する能力を増大する方法、複合体並びに液体媒体中のリガンドを測定するための均一系特異的結合分析法、均一系免疫分析法、試薬及